Glenmede Trust’s Ardelyx ARDX Stock Holding History

Glenmede Trust’s Portfolio ARDX Stock Details ARDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,110	Closed	-$21K	–	1263
2020 Q3	$21K	Hold	4,110	–	–	﹤0.01%	1592
2020 Q2	$28K	Buy	+4,110	New	+$28.6K	﹤0.01%	1463
2017 Q4	–	Sell	-3,960	Closed	-$22K	–	2670
2017 Q3	$22K	Hold	3,960	–	–	﹤0.01%	1925
2017 Q2	$50K	Hold	3,960	–	–	﹤0.01%	1597
2017 Q1	$50K	Hold	3,960	–	–	﹤0.01%	1597
2016 Q4	$56K	Hold	3,960	–	–	﹤0.01%	1577
2016 Q3	$51K	Hold	3,960	–	–	﹤0.01%	1604
2016 Q2	$34K	Sell	3,960 -413	-9%	-$3.37K	﹤0.01%	1706
2016 Q1	$33K	Hold	4,373	–	–	﹤0.01%	1654
2015 Q4	$79K	Hold	4,373	–	–	﹤0.01%	1424
2015 Q3	$75K	Buy	4,373 +413	+10%	+$7.71K	﹤0.01%	1454
2015 Q2	$63K	Hold	3,960	–	–	﹤0.01%	1553
2015 Q1	$51K	Hold	3,960	–	–	﹤0.01%	1672
2014 Q4	$74K	Buy	+3,960	New	+$91.7K	﹤0.01%	1631

Other funds holding ARDX

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Glenmede Trust's ARDX Position: Q4 2020 in Review

Glenmede Trust sold out of Ardelyx (ARDX) in Q4 2020, closing a stake of 4,110 shares — an estimated $21K sold.

Glenmede Trust first reported a position in ARDX in Q4 2014 and held it in 14 quarters. The position peaked at $79K in Q4 2015. 122 funds tracked by Wall St. Rank hold ARDX as of Q4 2020.

Glenmede Trust reported no remaining Ardelyx position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 4,110 Ardelyx shares in Q4 2020, an estimated $21K.
Glenmede Trust first reported a position in Ardelyx in Q4 2014 and held it in 14 quarters.
Glenmede Trust's Ardelyx position peaked at $79K in Q4 2015.
122 funds tracked by Wall St. Rank held Ardelyx as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.